|
1.
|
Johansson B, Fioretos T and Mitelman F:
Cytogenetic and molecular genetic evolution of chronic myeloid
leukemia. Acta Haematol. 107:76–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Sinclair PB, Nacheva EP, Leversha M,
Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B and Green
AR: Large deletions at the t(9;22) breakpoint are common and may
identify a poor-prognosis subgroup of patients with chronic myeloid
leukemia. Blood. 95:738–743. 2000.PubMed/NCBI
|
|
3.
|
Huntly BJP, Bench A and Green AR: Double
jeopardy from a single translocation: deletions of the derivative
chromosome 9 in chronic myeloid leukemia. Blood. 102:1160–1168.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Reid AG, Huntly BJ, Grace C, Green AR and
Nacheva EP: Survival implications of molecular heterogeneity in
variant Philadelphia-positive chronic myeloid leukaemia. Br J
Haematol. 121:419–427. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Bennour A, Sennana H, Laatiri MA, Elloumi
M, Khelif A and Saad A: Molecular cytogenetic characterization of
variant Philadelphia translocations in chronic myeloid leukemia:
genesis and deletion of derivative chromosome 9. Cancer Genet
Cytogenet. 194:30–37. 2009. View Article : Google Scholar
|
|
6.
|
Griffen J: The biology of signal
transduction inhibition: basic science to novel therapies. Semin
Oncol. 28:3–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kantarjian H, Sawyers C, Hochhaus A, et
al: International STI571 CML Study Group: Hematologic and
cytogenetic responses to imatinib mesylate in chronic myelogenous
leukemia. N Engl J Med. 346:645–652. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Cortes JE, Talpaz M, Giles F, O’Brien S,
Rios MB, Shan J, Garcia-Manero G, Faderl S, Thomas DA, Wierda W,
Ferrajoli A, Jeha S and Kantarjian HM: Prognostic significance of
cytogenetic clonal evolution in patients with chronic myelogenous
leukemia on imatinib mesylate therapy. Blood. 101:3794–3800. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Shaffer L, Slovak M and Cambell L: ISCN
(2009): An International System for Human Cytogenetic Nomenclature.
S. Karger; Basel: 2009
|
|
11.
|
Al-Achkar W, Wafa A and Nweder MS: A
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous
leukemia. J Exp Clin Cancer Res. 26:411–415. 2007.PubMed/NCBI
|
|
12.
|
Weise A, Mrasek K, Fickelscher I, Claussen
U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition
of high-resolution multicolor banding probes: first within the
human DNA sequence anchored FISH banding probe set. J Histochem
Cytochem. 56:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Liehr T, Heller A, Starke H, Rubtsov N,
Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U:
Microdissection based high resolution multicolor banding for all 24
human chromosomes. Int J Mol Med. 9:335–339. 2002.PubMed/NCBI
|
|
14.
|
Al-Achkar W, Wafa A, Ali BY, Manvelyan M
and Liehr T: A rare chronic myeloid leukemia case with Philadelphia
chromosome, BCR-ABL e13a3 transcript and complex translocation
involving four different chromosomes. Oncol Lett. 1:797–800.
2010.PubMed/NCBI
|
|
15.
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations in Cancer, 2009.
http://cgap.nci.nih.gov/Chromosomes/Mitelman.
|
|
16.
|
Dong JT, Lamb PW, Rinker-Schaeffer CW,
Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a
metastasis suppressor gene for prostate cancer on human chromosome
11p11.2. Science. 268:884–886. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Suzuki H, Dong JT, Gao AC, Barrett JC and
Issacs JT: Identification of the rat homologue of KAI1 and its
expression in Dunning rat prostate cancers. Prostate. 37:253–260.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yang X, Wei LL, Tang C, Slack R, Mueller S
and Lippman ME: Overexpression of KAI1 suppresses in vitro
invasiveness and in vivo metastasis in breast cancer cells. Cancer
Res. 61:5284–5288. 2001.PubMed/NCBI
|
|
19.
|
An Q, Wright SL, Moorman AV, Parker H,
Griffiths M, Ross FM, Davies T, Harrison CJ and Strefford JC:
Heterogeneous breakpoints in patients with acute lymphoblastic
leukemia and the dic(9;20)(p11∼13;q11) show recurrent involvement
of genes at 20q11.21. Haematologica. 94:1164–1169. 2009.PubMed/NCBI
|
|
20.
|
An Q, Wright SL, Konn ZJ, Matheson E,
Minto L, Moorman AV, Parker H, Griffiths M, Ross FM, Davies T, Hall
AG, Harrison CJ, Irving JA and Strefford JC: Variable breakpoints
target PAX5 in patients with dicentric chromosomes: A model for the
basis of unbalanced translocations in cancer. Proc Natl Acad Sci
USA. 105:17050–17054. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Yamazaki H, Nakata T, Okada Y and Hirokawa
N: KIF3A/B: a heterodimeric kinesin superfamily protein that works
as a microtubule plus end-directed motor for membrane organelle
transport. J Cell Biol. 130:1387–1399. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yamazaki H, Nakata T, Okada Y and Hirokawa
N: Cloning and characterization of KAP3: a novel kinesin
superfamily-associated protein of KIF3A/3B. Proc Natl Acad Sci USA.
93:8443–8448. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Estes DA, Lovato DM, Khawaja HM, Winter SS
and Larson RS: Genetic alterations determine chemotherapy
resistance in childhood T-ALL: modelling in stage-specific cell
lines and correlation with diagnostic patient samples. Br J
Haematol. 139:20–30. 2007. View Article : Google Scholar
|
|
24.
|
Kreil S, Pfirrmann M, Haferlach C, Waghorn
K, Chase A, Hehlmann R, Reiter A, Hochhaus A and Cross NC; German
Chronic Myelogenous Leukemia (CML) Study Group: Heterogeneous
prognostic impact of derivative chromosome 9 deletions in chronic
myelogenous leukemia. Blood. 110:1283–1290. 2007. View Article : Google Scholar : PubMed/NCBI
|
